Barbara Schrörs
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in ⓘ
- Immunology 15
- Immunotherapy and Immune Responses 15
- Oncology 13
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 6
- Co-authors
- Martin Löwer (16 shared papers)Uğur Şahin (16 shared papers)Özlem Türeci (6 shared papers)Mathias Vormehr (5 shared papers)Arbel D. Tadmor (3 shared papers)Sebastian Boegel (3 shared papers)Franziska Lang (7 shared papers)Fulvia Vascotto (5 shared papers)
- Journals
- Nature Reviews Drug Discovery (2 papers)OncoImmunology (2 papers)iScience (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Bioinformatics (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Barbara Schrörs
22 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Immunology 1.2k
- Oncology 1.0k
- Molecular Biology 783
- Cancer Research 141
- Radiology, Nuclear Medicine and Imaging 175
Countries citing papers authored by Barbara Schrörs
This map shows the geographic impact of Barbara Schrörs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Schrörs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Schrörs more than expected).
Fields of papers citing papers by Barbara Schrörs
This network shows the impact of papers produced by Barbara Schrörs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Schrörs. The network helps show where Barbara Schrörs may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Schrörs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutant MHC class II epitopes drive therapeutic immune responses to cancer Hit paper breakdown → | 2015 | 915 |
| 2 | Identification of neoantigens for individualized therapeutic cancer vaccines Hit paper breakdown → | 2022 | 330 |
| 3 | 2020 | 141 | |
| 4 | 2016 | 57 | |
| 5 | 2020 | 42 | |
| 6 | 2020 | 41 | |
| 7 | 2018 | 38 | |
| 8 | 2022 | 34 | |
| 9 | 2015 | 34 | |
| 10 | 2021 | 26 | |
| 11 | 2017 | 25 | |
| 12 | 2018 | 25 | |
| 13 | 2021 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 1 |
About Barbara Schrörs
Barbara Schrörs is a scholar working on Immunology, Oncology, Cancer Research, Otorhinolaryngology and Molecular Biology, having authored 23 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (11 papers), vaccines and immunoinformatics approaches (9 papers), CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Genomics and Diagnostics (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.0k citations), Molecular Biology (783 citations), Cancer Research (141 citations) and Radiology, Nuclear Medicine and Imaging (175 citations). Barbara Schrörs has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Martin Löwer, Uğur Şahin, Özlem Türeci, Mathias Vormehr, Arbel D. Tadmor, Sebastian Boegel, Franziska Lang, Fulvia Vascotto, Sebastian Kreiter and Mustafa Diken. Their work appears in journals such as Nature Reviews Drug Discovery, OncoImmunology, iScience, International Journal of Radiation Oncology*Biology*Physics and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.